Determining Factors for Hospital Discharge Status After Radical Cystectomy in a Large Contemporary Cohort
Monty Aghazadeh(Vanderbilt University Medical Center), Sam S. Chang(Memorial Sloan Kettering Cancer Center), Justin R. Gregg(The University of Texas MD Anderson Cancer Center), Shady Salem(Vanderbilt University Medical Center), C.J. Stimson(Johns Hopkins University), Michael S. Cookson(University of Oklahoma Health Sciences Center), Daniel A. Barocas(Vanderbilt University Medical Center), Peter E. Clark(Levine Cancer Institute), Joseph A. Smith(King's College London), Rodney Davis(The University of Texas MD Anderson Cancer Center)
Cited by 70
Related Papers
The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia
|New England Journal of Medicine|2003|2k
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
|The Journal of Urology|2007|1.1k
Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes
|The Journal of Urology|2007|845
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|592